These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36718062)

  • 21. Transcriptomic and epigenetic changes in early liver steatosis associated to obesity: effect of dietary methyl donor supplementation.
    Cordero P; Campion J; Milagro FI; Martinez JA
    Mol Genet Metab; 2013 Nov; 110(3):388-95. PubMed ID: 24084163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
    Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression.
    Ramezani M; Zobeiry M; Abdolahi S; Hatami B; Zali MR; Baghaei K
    Pathol Res Pract; 2023 Nov; 251():154809. PubMed ID: 37797383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism.
    Chen L; Huang W; Wang L; Zhang Z; Zhang F; Zheng S; Kong D
    Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):259-270. PubMed ID: 32124651
    [No Abstract]   [Full Text] [Related]  

  • 25. MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
    Fang Z; Dou G; Wang L
    Int J Biol Sci; 2021; 17(7):1851-1863. PubMed ID: 33994867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics.
    Radziejewska A; Muzsik A; Milagro FI; Martínez JA; Chmurzynska A
    Lifestyle Genom; 2020; 13(2):53-63. PubMed ID: 31846961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease.
    Lombardi R; Iuculano F; Pallini G; Fargion S; Fracanzani AL
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD).
    Subramanian P; Hampe J; Tacke F; Chavakis T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetics in hepatocellular carcinoma.
    Nagaraju GP; Dariya B; Kasa P; Peela S; El-Rayes BF
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):622-632. PubMed ID: 34324953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulation in alcoholic liver disease.
    Mandrekar P
    World J Gastroenterol; 2011 May; 17(20):2456-64. PubMed ID: 21633650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial dysfunction and epigenetics underlying the link between early-life nutrition and non-alcoholic fatty liver disease.
    La Colla A; Cámara CA; Campisano S; Chisari AN
    Nutr Res Rev; 2023 Dec; 36(2):281-294. PubMed ID: 35067233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease.
    Schiöth HB; Boström A; Murphy SK; Erhart W; Hampe J; Moylan C; Mwinyi J
    BMC Genomics; 2016 Jun; 17():462. PubMed ID: 27301979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
    Farrell GC; Haczeyni F; Chitturi S
    Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte-specific deletion of Brg1 alleviates methionine-and-choline-deficient diet (MCD) induced non-alcoholic steatohepatitis in mice.
    Kong M; Chen X; Xu H; Wenping ; Fang M; Xu Y
    Biochem Biophys Res Commun; 2018 Sep; 503(1):344-351. PubMed ID: 29890136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease.
    Hagiwara S; Nishida N; Ueshima K; Minami Y; Komeda Y; Aoki T; Takita M; Morita M; Chishina H; Yoshida A; Ida H; Kudo M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
    Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
    World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD).
    Del Campo JA; Gallego-Durán R; Gallego P; Grande L
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Epigenetic Control of Mitochondrial (Dys)Function in MASLD Onset and Progression.
    Caputo V; Tarantino G; Santini SJ; Fracassi G; Balsano C
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetics and mitochondrial dysfunction insights into the impact of the progression of non-alcoholic fatty liver disease.
    Guha S; Sesili S; Mir IH; Thirunavukkarasu C
    Cell Biochem Funct; 2023 Jan; 41(1):4-19. PubMed ID: 36330539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.